<DOC>
	<DOCNO>NCT00636753</DOCNO>
	<brief_summary>The purpose study determine whether antipsychotic treatment influence psychiatric patient due endocrine metabolic status quality life .</brief_summary>
	<brief_title>Antipsychotics Metabolic Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Gender male Age 1845 Debut drugnaive schizophrenic , Caucasians Consent give take part project Complianceproblems Major lung/kidney/hart/lever disorder Abuse alcohol/drugs Diabetes 1 2 Antihypertensive Anticholesterolreducing medication Patients duress</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Metabolic endocrine change schizophrenic patient antipsychotic treatment .</keyword>
</DOC>